
Bactrim Forte
$30.00
Description
Bactrim Forte
Bactrim Forte is a high-potency, prescription-only combination oral antibacterial medication manufactured by Roche Pharmaceuticals. It contains a synergistic blend of two synthetic antimicrobial agents: sulfamethoxazole (800 mg) and trimethoprim (160 mg). As a “Forte” formulation, it delivers a double-strength dose designed to treat a wide array of severe, acute bacterial infections.
Synergistic Mechanism of Action
Bactrim Forte operates by delivering a dual-stage disruption of bacterial metabolism, blocking a process known as the folate synthesis pathway:
• Stage 1 (Sulfamethoxazole): Sulfamethoxazole acts as a structural analog to para-aminobenzoic acid (PABA), competing for the enzyme needed to synthesize dihydropteroic acid [nih.gov]. This halts the initial stage of bacterial folic acid production.
• Stage 2 (Trimethoprim): Trimethoprim binds to and inhibits the enzyme dihydrofolate reductase [nih.gov], blocking the final activation step of folic acid.
• The Clinical Result: By interrupting two sequential steps, the combination shifts from a bacteriostatic (growth-inhibiting) effect to a powerful bactericidal (bacterial-killing) effect, drastically reducing the chances of the bacteria developing resistance.
Product Profile & Specifications
• Brand Name: Bactrim Forte.
• Manufacturer: Roche Pharmaceuticals.
• Active Composition: 800 mg Sulfamethoxazole and 160 mg Trimethoprim per tablet [nih.gov].
• Administration Form: Oral tablets (supplied in convenient 10-tablet blister sheets).
• Onset of Action: Rapid systemic absorption, with peak therapeutic blood levels achieved within 1 to 4 hours after ingestion.
• Chemical Drug Class: Sulfonamide combination / Folate antagonists.
Clinical Indications & Everyday Target Uses
Bactrim Forte is highly effective at treating broad-spectrum gram-positive and gram-negative bacterial infections:
• Urinary Tract Infections (UTIs): Highly effective against severe or recurrent bladder and kidney infections [nih.gov].
• Respiratory Care: Prescribed for acute bacterial exacerbations of chronic bronchitis and specialized middle ear infections (otitis media).
• Gastrointestinal Infections: Targets traveler’s diarrhea and shigellosis enteritis [nih.gov].
• Skin & Soft Tissue Infections: Utilized off-label for treating stubborn, community-acquired MRSA staph skin infections.



Reviews
There are no reviews yet.